Plavix, a drug popular slimming blood, is the target of several complaints from users and third-party payors, cargo, that producers, Bristol-Myers Squibb and Sanofi-Aventis markets USA the drug in defiance of their potential health risks.
In five complaints filed Monday in federal court in Trenton, New Jersey, and two cases in October, the claimants allege that manufacturers promote Plavix and SSA as a common regime for the prevention of blood clots, if the security of therapy n ‘ is not known.
The applicants state that producers “subsidized” drugs and two were commissioned by the Food and Drug Administration, announcements, claims overly broad.
Plavix was the second drug most frequently prescribed in the world during the year 2005 with a turnover of U.S. $ 5.9 billion, after the drug market research company IMS Fairfield, Conn.
A study published on 20 April in The New England Journal of Medicine, said Plavix with aspirin is not more effective than aspirin alone, and was harmful in patients with several risk factors like hypertension or high cholesterol.
“Despite the growing body of scientific knowledge, that four dollars Plavix pill was not much better than one hundred eighty-A-Day aspirin, defendant held to promote public and physicians, with exaggeration of counterfeiting and finally in the process “Claimants allege.
It also agrees that Plavix tax causes severe and sometimes fatal injuries. Among the claimants is to Eloise LaBarr Bonifay, Florida, whose husband, Edward began with the taking of aspirin, Plavix after coronary bypass with a stent placement to repair a blocked artery in November 2002. In December 2004, he collapsed after suffering serious intracranial bleeding and injuries to life remained care two days before death imposed by a hematoma subdurales and “Plavix therapy” as the causes of his death certificate color.
Another claimant, Patricia Begley Crystal Lake, Ill., she aspirin, Plavix and December 2003 to January 2006, after implantation of a stent. You arrested after crashed to the hospital for internal bleeding, a blood transfusion, a week’s stay at the hospital and one week in a rest home, according to their color.
The costumes are counts of negligent deception, design and manufacturing defect, breach of implied warranty, failure to warn and offences against New Jersey, the law on product liability, NJSA 2A: 58C-1 and seq. And the New Jersey Consumer Fraud Act, NJSA 56.8-1 et seq. The claimants seek compensatory measures and punitive damages.
One of the complaints filed in October, a so-called class action on behalf of third party payer, as HMOs.